Correlation Between Mineralys Therapeutics, and Generation Bio
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Generation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Generation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Generation Bio Co, you can compare the effects of market volatilities on Mineralys Therapeutics, and Generation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Generation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Generation Bio.
Diversification Opportunities for Mineralys Therapeutics, and Generation Bio
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Mineralys and Generation is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Generation Bio Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generation Bio and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Generation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generation Bio has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Generation Bio go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Generation Bio
Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 42.33 times less return on investment than Generation Bio. But when comparing it to its historical volatility, Mineralys Therapeutics, Common is 3.38 times less risky than Generation Bio. It trades about 0.01 of its potential returns per unit of risk. Generation Bio Co is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 385.00 in Generation Bio Co on June 1, 2025 and sell it today you would earn a total of 232.00 from holding Generation Bio Co or generate 60.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Generation Bio Co
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Generation Bio |
Mineralys Therapeutics, and Generation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Generation Bio
The main advantage of trading using opposite Mineralys Therapeutics, and Generation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Generation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will offset losses from the drop in Generation Bio's long position.| Mineralys Therapeutics, vs. ioneer Ltd American | Mineralys Therapeutics, vs. Getty Copper | Mineralys Therapeutics, vs. AerSale Corp | Mineralys Therapeutics, vs. Austin Gold Corp |
| Generation Bio vs. China Pharma Holdings | Generation Bio vs. China SXT Pharmaceuticals | Generation Bio vs. HeartCore Enterprises | Generation Bio vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |